Alnylam Pharmaceuticals (ALNY) Shareholder's Equity Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.20% |
| Dec 31, 2025 | 91.18% |
| Sep 30, 2025 | 76.07% |
| Jun 30, 2025 | 12.49% |
| Mar 31, 2025 | 2.03% |
| Dec 31, 2024 | -51.50% |
| Sep 30, 2024 | -65.02% |
| Jun 30, 2024 | -26.07% |
| Mar 31, 2024 | -30.78% |
| Dec 31, 2023 | -30.40% |
| Sep 30, 2023 | -28.80% |
| Jun 30, 2023 | -31.84% |
| Mar 31, 2023 | -29.90% |
| Dec 31, 2022 | -28.26% |
| Sep 30, 2022 | -26.87% |
| Jun 30, 2022 | -53.56% |
| Mar 31, 2022 | -36.23% |
| Dec 31, 2021 | -23.27% |
| Sep 30, 2021 | -20.03% |
| Jun 30, 2021 | -19.25% |
| Mar 31, 2021 | -19.19% |
| Dec 31, 2020 | -16.83% |
| Sep 30, 2020 | 4.69% |
| Jun 30, 2020 | 7.62% |
| Mar 31, 2020 | 17.55% |
| Dec 31, 2019 | 16.06% |
| Sep 30, 2019 | 16.55% |
| Jun 30, 2019 | 16.95% |
| Mar 31, 2019 | 9.17% |
| Dec 31, 2018 | 0.97% |
| Sep 30, 2018 | 3.80% |
| Jun 30, 2018 | 4.79% |
| Mar 31, 2018 | 5.45% |
| Dec 31, 2017 | 23.57% |
| Sep 30, 2017 | 5.39% |
| Jun 30, 2017 | 6.02% |
| Mar 31, 2017 | -4.53% |
| Dec 31, 2016 | 50.43% |
| Sep 30, 2016 | 50.53% |
| Jun 30, 2016 | 52.76% |
| Mar 31, 2016 | 56.27% |
| Dec 31, 2015 | 111.30% |
| Sep 30, 2015 | 95.39% |
| Jun 30, 2015 | 95.58% |
| Mar 31, 2015 | 96.45% |
| Dec 31, 2014 | 99.45% |
| Sep 30, 2014 | 91.96% |
| Jun 30, 2014 | 90.38% |
| Mar 31, 2014 | 87.20% |
| Dec 31, 2013 | 19.55% |
| Sep 30, 2013 | 22.81% |
| Jun 30, 2013 | 23.03% |
| Dec 31, 2012 | -9.01% |